Combination of treating and/or preventing hemorrhoid

A kind of composition, the technology of medicine, be used in the field of combination therapy for the treatment of hemorrhoids, and the field of pharmaceutical compositions for the treatment and/or prevention of hemorrhoids

Inactive Publication Date: 2011-09-07
BEIJING BIOSIS HEALING BIOLOGICAL TECH
View PDF14 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, there is no literature report on the use of NOS inhibitors for the treatment of hemorrhoids and the preparation of drugs for the treatment of hemorrhoids

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Combination of treating and/or preventing hemorrhoid
  • Combination of treating and/or preventing hemorrhoid
  • Combination of treating and/or preventing hemorrhoid

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0093] Example 1: Differences in MVD and elastic fibers between hemorrhoid tissue and relatively normal anal cushion tissue, as well as the expression and difference of NOS, PDE5, VEGF, MMP1, 3, 9, and 12

[0094] 1. Materials and methods

[0095] Selected 24 cases of suprahemorrhoidal mucosal circumcision and stapling (PPH surgery) specimens obtained from October 2003 to August 2004, mainly selecting one or two female hemorrhoids among the three female hemorrhoids with obvious lesions, but at least one female hemorrhoid Internal hemorrhoid specimens from patients with grade III hemorrhoids with inconspicuous "hemorrhoids" lesions. The patients were aged between 35-60. After PPH operation, the protruding female hemorrhoid tissue and relatively normal anal cushion tissue were fixed in 15% neutral formalin solution, embedded in paraffin, and serially sectioned.

[0096] Paraffin sections from all patients were stained by H.E. immunohistochemical streptavidin-biotin-peroxidase-...

Embodiment 2

[0116]Example 2: Preparation of Suppository A Containing At Least One Nitric Oxide Synthase Inhibitor At Least One Angiogenesis Inhibitor And At Least One Matrix Metalloproteinase Inhibitor

[0117] With conventional suppository preparation method, the following compounds are mixed in the content ratio described in the table (table 2):

[0118] Table 2: Composition and content of each component of suppository A

[0119]

[0120] Specifically, the production method is to gradually add other ingredients described in Table 2 to the heated and melted aliphatic base—cocoa butter, while stirring continuously and making it uniformly dispersed. Upon cooling to about 50°C, the mixture is poured into suppository containers and further cooled to give suppositories. The quality of each suppository prepared according to the above method is 4g.

[0121] In addition, by changing the aliphatic base in the ingredients described in Table 2 to pure water, a corresponding ointment can be mad...

Embodiment 3

[0122] Example 3: Preparation of Suppository B Containing At Least One Nitric Oxide Synthase Inhibitor At Least One Angiogenesis Inhibitor And At Least One Matrix Metalloproteinase Inhibitor

[0123] With conventional suppository preparation method, the following compounds are mixed according to the content ratio described in the table (table 3):

[0124] Table 3: Composition and content of each component of suppository A

[0125]

[0126] Specifically, the production method is to gradually add other ingredients described in Table 3 to the heated and melted aliphatic base—cocoa butter, while stirring continuously and making it uniformly dispersed. Upon cooling to about 50°C, the mixture is poured into suppository containers and further cooled to give suppositories. The quality of each suppository prepared according to the above method is 4g.

[0127] In addition, by changing the aliphatic base in the ingredients described in Table 3 to pure water, a corresponding ointment...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A composition for preventing and / or treating piles contains at least one NO synthetase (NOS) inhibitor, especially iNOS inhibitor, at least one vascular angiogenesis inhibitor, especially VEGF inhibitor, and at least one matrix metal proteinase (MMP) inhibitor, especially MMP1, MMP3, MMP9 and / or MMP12 inhibitor.

Description

Technical field: [0001] The present invention relates to the preparation of a pharmaceutical composition for treating and / preventing hemorrhoids. The pharmaceutical composition comprises at least one nitric oxide synthase inhibitor, at least one angiogenesis inhibitor and at least one matrix metalloproteinase inhibitor. The pharmaceutical composition can be suppository, ointment, cream, fumigant, lozenge, tablet, pill, capsule, powder, granule, injection and / or oral liquid, preferably suppository. The present invention also relates to a combination therapy for the treatment of hemorrhoids comprising the combined administration of nitric oxide synthase inhibitors, angiogenesis inhibitors and matrix metalloproteinase inhibitors. Background of the invention: [0002] Hemorrhoids are the pathological changes and (or) abnormal displacement of the supporting structure of the anal cushion (anal canal vascular cushion), vascular plexus and arteriovenous anastomotic branches, which ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K45/06A61P9/14
Inventor 王振军赵博韩炜
Owner BEIJING BIOSIS HEALING BIOLOGICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap